Clinical Trial Update: Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating patiromer titration in heart failure patients with chronic kidney disease; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Relypsa, Inc. | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2016-01-28